Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.2%
    Check dated 2025-01-19T23:56:23.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.1%
    Check dated 2025-01-12T19:00:23.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has updated the 'Last Update Posted' information, removing the 'Estimated' qualifier.
    Difference
    0.0%
    Check dated 2024-12-22T03:17:37.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated with new entries for December 2024, including a revision to version 2.13.3, while previous updates from October 2024 and earlier have been removed.
    Difference
    0.6%
    Check dated 2024-12-14T23:00:55.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T16:50:13.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Several key resources related to genetics and rare diseases have been removed, including links to MedlinePlus and ClinicalTrials.gov, which may impact access to important medical information.
    Difference
    3%
    Check dated 2024-11-23T05:10:40.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.